Subodh Verma (S Verma)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 76

Top Topics

Left Ventricular

Ejection Fraction

Top Venues

Diabetes, obesity & metabolism

American journal of physiology. Heart and circulatory physiology

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Brady Park, Aishwarya Krishnaraj, Hwee Teoh, Ehab Bakbak, Fallon Dennis, Adrian Quan, David A Hess, Subodh Verma
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes. American journal of physiology. Heart and circulatory physiology 327 (2) (2024)
Brady Park, Ehab Bakbak, Hwee Teoh, Aishwarya Krishnaraj, Fallon Dennis, Adrian Quan, Ori D Rotstein, Javed Butler, David A Hess, Subodh Verma
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage. American journal of physiology. Heart and circulatory physiology 326 (5) (2024)
Subodh Verma, Lawrence A Leiter, Kamal K Mangla, Nick F Nielsen, Yasemin Hansen, Marc P Bonaca
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Amgad Mentias, Milind Y Desai, Ali Aminian, Kershaw V Patel, Neil Keshvani, Subodh Verma, Leslie Cho, Miriam Jacob, Paulino Alvarez, A Michael Lincoff, Harriette Gillian Christine Van Spall, Carolyn Su Ping Lam, Javed Butler, Steven E Nissen, Ambarish Pandey
Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity. Circulation. Heart failure (2024)
Amgad Mentias, Milind Y Desai, Ali Aminian, Kershaw V Patel, Neil Keshvani, Subodh Verma, Leslie Cho, Miriam Jacob, Paulino Alvarez, A Michael Lincoff, Harriette Gillian Christine Van Spall, Carolyn Su Ping Lam, Javed Butler, Steven E Nissen, Ambarish Pandey
Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity. Circulation. Heart failure 17 (2) (2024)
Brady Park, Ehab Bakbak, Hwee Teoh, Aishwarya Krishnaraj, Fallon Dennis, Adrian Quan, Ori D Rotstein, Javed Butler, David A Hess, Subodh Verma
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage. American journal of physiology. Heart and circulatory physiology 326 (5) (2024)
Brady Park, Ehab Bakbak, Hwee Teoh, Aishwarya Krishnaraj, Fallon Dennis, Adrian Quan, Ori D Rotstein, Javed Butler, David A Hess, Subodh Verma
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage. American journal of physiology. Heart and circulatory physiology 326 (5) (2024)
Brady Park, Aishwarya Krishnaraj, Hwee Teoh, Ehab Bakbak, Fallon Dennis, Adrian Quan, David A Hess, Subodh Verma
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes. American journal of physiology. Heart and circulatory physiology 327 (2) (2024)
Subodh Verma, Lawrence A Leiter, Kamal K Mangla, Nick F Nielsen, Yasemin Hansen, Marc P Bonaca
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Subodh Verma, Lawrence A Leiter, Kamal K Mangla, Nick F Nielsen, Yasemin Hansen, Marc P Bonaca
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Amgad Mentias, Milind Y Desai, Ali Aminian, Kershaw V Patel, Neil Keshvani, Subodh Verma, Leslie Cho, Miriam Jacob, Paulino Alvarez, A Michael Lincoff, Harriette Gillian Christine Van Spall, Carolyn Su Ping Lam, Javed Butler, Steven E Nissen, Ambarish Pandey
Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity. Circulation. Heart failure 17 (2) (2024)
Qi Zhang, Nobuhiro Yaoita, Arata Tabuchi, Shao-Fei Liu, Shiau-Haln Chen, Qiuhua Li, Niklas Hegemann, Caihong Li, Julie Rodor, Sara Timm, Hebatullah Laban, Toren Finkel, Troy Stevens, Diego F Alvarez, Lasti Erfinanda, Marc de Perrot, Mariya M Kucherenko, Christoph Knosalla, Matthias Ochs, Stefanie Dimmeler, Thomas Korff, Subodh Verma, Andrew H Baker, Wolfgang M Kuebler
Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension. Circulation 150 (6) (2024)
Qi Zhang, Nobuhiro Yaoita, Arata Tabuchi, Shao-Fei Liu, Shiau-Haln Chen, Qiuhua Li, Niklas Hegemann, Caihong Li, Julie Rodor, Sara Timm, Hebatullah Laban, Toren Finkel, Troy Stevens, Diego F Alvarez, Lasti Erfinanda, Marc de Perrot, Mariya M Kucherenko, Christoph Knosalla, Matthias Ochs, Stefanie Dimmeler, Thomas Korff, Subodh Verma, Andrew H Baker, Wolfgang M Kuebler
Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension. Circulation (2024)
Brady Park, Aishwarya Krishnaraj, Hwee Teoh, Ehab Bakbak, Fallon Dennis, Adrian Quan, David A Hess, Subodh Verma
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes. American journal of physiology. Heart and circulatory physiology 327 (2) (2024)
Brady Park, Ehab Bakbak, Hwee Teoh, Aishwarya Krishnaraj, Fallon Dennis, Adrian Quan, Ori D Rotstein, Javed Butler, David A Hess, Subodh Verma
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage. American journal of physiology. Heart and circulatory physiology 326 (5) (2024)
Subodh Verma, Lawrence A Leiter, Kamal K Mangla, Nick F Nielsen, Yasemin Hansen, Marc P Bonaca
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Subodh Verma, Lawrence A Leiter, Kamal K Mangla, Nick F Nielsen, Yasemin Hansen, Marc P Bonaca
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (9) (2024)
Brady Park, Aishwarya Krishnaraj, Hwee Teoh, Ehab Bakbak, Fallon Dennis, Adrian Quan, David A Hess, Subodh Verma
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes. American journal of physiology. Heart and circulatory physiology 327 (2) (2024)
Brady Park, Ehab Bakbak, Hwee Teoh, Aishwarya Krishnaraj, Fallon Dennis, Adrian Quan, Ori D Rotstein, Javed Butler, David A Hess, Subodh Verma
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage. American journal of physiology. Heart and circulatory physiology 326 (5) (2024)
Amgad Mentias, Milind Y Desai, Ali Aminian, Kershaw V Patel, Neil Keshvani, Subodh Verma, Leslie Cho, Miriam Jacob, Paulino Alvarez, A Michael Lincoff, Harriette Gillian Christine Van Spall, Carolyn Su Ping Lam, Javed Butler, Steven E Nissen, Ambarish Pandey
Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity. Circulation. Heart failure 17 (2) (2024)
Subodh Verma, Avinash Pandey, Arjun K Pandey, Javed Butler, John S Lee, Hwee Teoh, C David Mazer, Mikhail N Kosiborod, Francesco Cosentino, Stefan D Anker, Kim A Connelly, Deepak L Bhatt
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease. American journal of physiology. Heart and circulatory physiology 326 (3) (2023)
Kershaw V Patel, Matthew W Segar, David C Klonoff, Muhammad Shahzeb Khan, Muhammad Shariq Usman, Carolyn Su Ping Lam, Subodh Verma, Andrew P DeFilippis, Khurram Nasir, Stephan J L Bakker, Berend Daan Westenbrink, Robin P F Dullaart, Javed Butler, Muthiah Vaduganathan, Ambarish Pandey
Optimal Screening for Predicting and Preventing the Risk of Heart Failure Among Adults With Diabetes Without Atherosclerotic Cardiovascular Disease: a Pooled Cohort Analysis. Circulation (2023)
Pankaj Puar, Shamon Ahmed, Makoto Hibino, Aryan Pasricha, Arjun Pandey, Amaan Bari, Raj Verma, Adrian Quan, Andrew T Yan, Kim A Connelly, Hwee Teoh, C David Mazer, Subodh Verma
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease. Diabetes, obesity & metabolism (2023)
Arjun K Pandey, Deepak L Bhatt, Avinash Pandey, Nikolaus Marx, Francesco Cosentino, Ambarish Pandey, Subodh Verma
Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction. European heart journal (2023)
Subodh Verma, Avinash Pandey, Arjun K Pandey, Javed Butler, John S Lee, Hwee Teoh, C David Mazer, Mikhail N Kosiborod, Francesco Cosentino, Stefan D Anker, Kim A Connelly, Deepak L Bhatt
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease. American journal of physiology. Heart and circulatory physiology 326 (3) (2023)
Subodh Verma, Avinash Pandey, Arjun K Pandey, Javed Butler, John S Lee, Hwee Teoh, C David Mazer, Mikhail N Kosiborod, Francesco Cosentino, Stefan D Anker, Kim A Connelly, Deepak L Bhatt
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease. American journal of physiology. Heart and circulatory physiology 326 (3) (2023)
Subodh Verma, Nitish K Dhingra, Marc P Bonaca, Javed Butler, Stefan D Anker, Joao Pedro Ferreira, Gerasimos S Filippatos, James L Januzzi, Carolyn Su Ping Lam, Naveed Sattar, Tomoko Iwata, Matias Nordaby, Martina Brueckmann, Stuart J Pocock, Milton Packer, null null
Presence of Peripheral Artery Disease Is Associated With Increased Risk of Heart Failure Events: Insights From EMPEROR-Pooled. Arteriosclerosis, thrombosis, and vascular biology (2023)
Subodh Verma, Jens-Peter David, Lawrence A Leiter, Marie Mide Michelsen, Søren Rasmussen, Deepak L Bhatt
Semaglutide reduces risk of MACE consistently across baseline triglyceride levels in patients with type 2 diabetes: Post Hoc Analyses of SUSTAIN 6 and PIONEER 6 trials. Diabetes, obesity & metabolism (2023)
Subodh Verma, Sunder Mudaliar, Peter J Greasley
Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium-Glucose Cotransporter 2 Inhibitors. Advances in therapy (2023)
Subodh Verma, Naji Alamuddin, Fatheya Alawadi, Hessa Alkandari, Wael Al Mahmeed, Samir H Assaad-Khalil, Jihad Haddad, Lise Lotte N Husemoen, Landman Lombard, Rayaz Ahmed Malik, Emel Mashaki Ceyhan, Hani Sabbour, Gamze Tombak, Gourav Yadav, Sam Salek
Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study. Circulation (2023)
Abhinav Sharma, Pedro Marques, Brendon L Neuen, Robert A Fletcher, April E Hebert, Wally Rapattoni, Fernando G Ang, Clare Arnott, Adeera Levin, Subodh Verma, Vlado Perkovic, Kenneth W Mahaffey
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial. Diabetes, obesity & metabolism (2023)
Subodh Verma, Mansoor Husain, Christian Medom Madsen, Lawrence A Leiter, Anja Birk Kuhlman, Tina Vilsbøll, Søren Rasmussen, Peter Libby
Neutrophil-lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials. Diabetes, obesity & metabolism (2023)
Barry A Borlaug, Dalane W Kitzman, Melanie J Davies, Søren Rasmussen, Eric Barros, Javed Butler, Mette Nygaard Einfeldt, G Kees Hovingh, Daniél Vega Møller, Mark C Petrie, Sanjiv J Shah, Subodh Verma, Walter P Abhayaratna, Fozia Z Ahmed, Vijay Chopra, Justin A Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtech Melenovsky, Julio Nunez, Eduardo Roque Perna, Morten Schou, Michele Senni, Peter Van der Meer, Dirk von Lewinski, Dennis Wolf, Mikhail Naum Kosiborod
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nature medicine (2023)
Pankaj Puar, Nikhil Mistry, Kim A Connelly, Andrew T Yan, Adrian Quan, Hwee Teoh, Yi Pan, Raj Verma, David A Hess, Subodh Verma, C David Mazer
IGFBP7 and left ventricular mass regression: a sub-analysis of the EMPA-HEART CardioLink-6 randomized clinical trial. ESC heart failure (2023)
Mikhail Naum Kosiborod, Subodh Verma, Barry A Borlaug, Javed Butler, Melanie J Davies, Thomas Jon Jensen, Søren Rasmussen, Peter Erlang Marstrand, Mark Colquhoun Petrie, Sanjiv J Shah, Hiroshi Ito, Morten Schou, Vojtech Melenovsky, Walter P Abhayaratna, Dalane W Kitzman
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial. Circulation (2023)
John Joseph Valentine McMurray, Kieran F Docherty, Rudolf A de Boer, Ann Hammarstedt, Dalane W Kitzman, Mikhail Naum Kosiborod, Anna Maria Langkilde, Barry Reicher, Michele Senni, Sanjiv J Shah, Ulrica Wilderäng, Subodh Verma, Scott D Solomon
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials. Circulation (2023)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Arjun K Pandey, Deepak L Bhatt, Francesco Cosentino, Nikolaus Marx, Ori Rotstein, Bertram Pitt, Ambarish Pandey, Javed Butler, Subodh Verma
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease. European heart journal 43 (31) (2022)
Carly Adamson, Kieran F Docherty, Hiddo J Lambers Heerspink, Rudolf A de Boer, Kevin Damman, Catherine M Viscoli, Lars Valeur Køber, Mikhail Naum Kosiborod, Felipe A Martinez, Mark Colquhoun Petrie, Piotr Ponikowski, Marc S Sabatine, Morten Schou, Scott D Solomon, Subodh Verma, Olof F Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Muthiah Vaduganathan, Pardeep S Jhund, John Joseph Valentine McMurray
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF. Circulation 146 (6) (2022)
Kieran F Docherty, Paul I Welsh, Subodh Verma, Rudolf A de Boer, Eileen O'Meara, Olof F Bengtsson, Lars Valeur Køber, Mikhail Naum Kosiborod, Ann Hammarstedt, Anna Maria Langkilde, Daniel Lindholm, Dustin J Little, Mikaela Sjöstrand, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, David A Morrow, Morten Schou, Scott D Solomon, Naveed Sattar, Pardeep S Jhund, John Joseph Valentine McMurray, null null
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF. Circulation 146 (13) (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Benjamin E Peterson, Deepak L Bhatt, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane S Pinto, Robert P Giugliano, Matthew J Budoff, Jean Claude Tardif, Subodh Verma, Christie M Ballantyne, null null
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI. Journal of the American Heart Association 11 (6) (2022)
Nikolaus Marx, Mansoor Husain, Michael Lehrke, Subodh Verma, Naveed Sattar
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. Circulation 146 (24) (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Nikolaus Marx, Mansoor Husain, Michael Lehrke, Subodh Verma, Naveed Sattar
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. Circulation 146 (24) (2022)
Subodh Verma, Nitish K Dhingra, Javed Butler, Stefan D Anker, Joao Pedro Ferreira, Gerasimos S Filippatos, James L Januzzi, Carolyn Su Ping Lam, Naveed Sattar, Egon Pfarr, Matias Nordaby, Martina Brueckmann, Stuart J Pocock, Faiez Zannad, Milton Packer
Empagliflozin in Black Versus White Patients with Heart Failure: Analysis of EMPEROR-Pooled. Circulation (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association (2022)
Kim A Connelly, C David Mazer, Pankaj Puar, Hwee Teoh, Chao-Hung Wang, Tamique Mason, Farhad Akhavein, Ching-Wen Chang, Min-Hui Liu, Ning-I Yang, Wei-Siang Chen, Yu-Hsiang Juan, Erika Opingari, Yaseen Salyani, William Barbour, Aryan Pasricha, Shamon Ahmed, Andrew Kosmopoulos, Raj Verma, Michael Moroney, Ehab Bakbak, Aishwarya Krishnaraj, Deepak L Bhatt, Javed Butler, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, David A Hess, Otávio Rizzi Coelho-Filho, Myriam Lafreniere-Roula, Kevin E Thorpe, Adrian Quan, Lawrence Alan Leiter, Andrew T Yan, Subodh Verma
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial. Circulation (2022)
Chih-Hao Chen, Mark D Peterson, C David Mazer, Makoto Hibino, Andrew E Beaudin, Michael W A Chu, François Dagenais, Hwee Teoh, Adrian Quan, Jeffrey Dickson, Subodh Verma, Eric Edward Smith
Acute Infarcts on Brain MRI Following Aortic Arch Repair With Circulatory Arrest: Insights From the ACE CardioLink-3 Randomized Trial. Stroke (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Ronald M Goldenberg, Alice Y Y Cheng, Tess Fitzpatrick, Jeremy D Gilbert, Subodh Verma, Julia J Hopyan
Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists. Stroke 53 (5) (2022)
Nikolaus Marx, Mansoor Husain, Michael Lehrke, Subodh Verma, Naveed Sattar
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. Circulation 146 (24) (2022)
Subodh Verma, Mohammed Al-Omran, Lawrence A Leiter, C David Mazer, Søren Rasmussen, Hans A Saevereid, Maria Sejersten Ripa, Marc P Bonaca
Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease. Diabetes, obesity & metabolism 24 (7) (2022)
Brian A Bergmark, Nicholas A Marston, Candace R Bramson, Madelyn Curto, Vesper Ramos, Alexandra Jevne, Julia F Kuder, Jeong-Gun Park, Sabina A Murphy, Subodh Verma, Wojciech Wojakowski, Steven G Terra, Marc S Sabatine, Stephen D Wiviott, null null
Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70. Circulation 145 (18) (2022)
Nikolaus Marx, Mansoor Husain, Michael Lehrke, Subodh Verma, Naveed Sattar
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. Circulation 146 (24) (2022)
Muhammad Shahzeb Khan, Javed Butler, Stefan D Anker, Gerasimos S Filippatos, Joao Pedro Ferreira, Stuart J Pocock, James L Januzzi, Iliana L Piña, Michael Böhm, Piotr Ponikowski, Subodh Verma, Martina Brueckmann, Ola Vedin, Cordula Zeller, Faiez Zannad, Milton Packer
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association 12 (1) (2022)
Michael Szarek, Deepak L Bhatt, Ph Gabriel Steg, Christopher P Cannon, Lawrence Alan Leiter, Darren K McGuire, Julia B Lewis, Matthew C Riddle, Adriaan A Voors, Marco Metra, Lars H Lund, Michel Komajda, Jeffrey M Testani, Christopher S Wilcox, Piotr Ponikowski, Renato Deláscio Lopes, Phillip Banks, Eshetu Tesfaye, Justin A Ezekowitz, Subodh Verma, Bertram Pitt, null null
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial. Annals of internal medicine 174 (8) (2021)
Subodh Verma, Deepak L Bhatt, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Nitish K Dhingra, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane Pinto, Robert P Giugliano, Matthew J Budoff, R Preston Mason, Jean Claude Tardif, Christie M Ballantyne, null null
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation 144 (23) (2021)
Arjun K Pandey, Iva Okaj, Hargun Kaur, Emilie P Belley-Cote, Jia Wang, Alireza Oraii, Alexander P Benz, Linda S B Johnson, Jack Young, Jorge Alfredo Wong, Subodh Verma, David Conen, Hertzel Gerstein, Jeffrey S Healey, William F Mcintyre
Sodium-Glucose Co-Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association 10 (17) (2021)
Subodh Verma, Udi Fainberg, Mansoor Husain, Søren Rasmussen, Lars Rydén, Maria Sejersten Ripa, John B Buse
Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide. Diabetes, obesity & metabolism 23 (7) (2021)
Subodh Verma, Deepak L Bhatt, Elaine E Tseng
Time to Remove the Left Atrial Appendage at Surgery: LAAOS III in Perspective. Circulation 144 (14) (2021)
Javed Butler, Gerasimos S Filippatos, Tariq Jamal Siddiqi, Martina Brueckmann, Michael Böhm, Vijay K Chopra, Joao Pedro Ferreira, James L Januzzi, Sanjay Kaul, Iliana L Piña, Piotr Ponikowski, Sanjiv J Shah, Michele Senni, Ola Vedin, Subodh Verma, Barbara Peil, Stuart J Pocock, Faiez Zannad, Milton Packer, Stefan D Anker
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial. Circulation (2021)
Subodh Verma, C David Mazer, Catherine M Viscoli, Christoph Wanner, Anne Pernille Ofstad, Odd Erik Johansen, Isabella Zwiener, Jyothis T George, Javed Butler, Bernard Zinman
Impact of polyvascular disease with and without co-existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA-REG OUTCOME. Diabetes, obesity & metabolism 23 (5) (2021)
David A Hess, Daniella C Terenzi, Subodh Verma
Heal Thyself: SGLT2 Inhibition Limits Regenerative Cell Exhaustion and Heals Damaged Vessels. Diabetes 70 (8) (2021)
Catherine M Viscoli, Kieran F Docherty, Lars Køber, Mikhail Naum Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Scott D Solomon, Subodh Verma, Jan Bělohlávek, Michael Böhm, Chern-En Chiang, Rudolf A de Boer, Mirta Diez, Andre Dukát, Charlotta E A Ljungman, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Pardeep S Jhund, John Joseph Valentine McMurray, null null
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF. Diabetes care 44 (2) (2020)
Matthew J Crowley, Darren K McGuire, Anastasia-Stefania Alexopoulos, Thomas Jon Jensen, Søren Rasmussen, Hans A Saevereid, Subodh Verma, John B Buse
Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial. Diabetes care 43 (9) (2020)
Subodh Verma, Abhinav Sharma, Bernard Zinman, Anne Pernille Ofstad, David H Fitchett, Martina Brueckmann, Christoph Wanner, Isabella Zwiener, Jyothis T George, Silvio E Inzucchi, Javed Butler, C David Mazer
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial. Diabetes, obesity & metabolism 22 (7) (2020)
Subodh Verma, Darren K McGuire, Stephen C Bain, Deepak L Bhatt, Lawrence A Leiter, C David Mazer, Tea Monk Fries, Richard E Pratley, Søren Rasmussen, Hrvoje Vrazic, Bernard Zinman, John B Buse
Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials. Diabetes, obesity & metabolism 22 (12) (2020)
Subodh Verma, Stephen C Bain, Julie Broe Honoré, Johannes F E Mann, Michael A Nauck, Richard E Pratley, Søren Rasmussen, Maria Sejersten Ripa, Bernard Zinman, John B Buse
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials. Diabetes, obesity & metabolism 22 (11) (2020)
Lawrence Alan Leiter, Stephen C Bain, Deepak L Bhatt, John B Buse, C David Mazer, Richard E Pratley, Søren Rasmussen, Maria Sejersten Ripa, Hrvoje Vrazic, Subodh Verma
The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials. Diabetes, obesity & metabolism 22 (9) (2020)
Subodh Verma, Qiuhe Ji, Deepak L Bhatt, C David Mazer, Mohammed Al-Omran, Silvio E Inzucchi, Christoph Wanner, Anne Pernille Ofstad, Isabella Zwiener, Jyothis T George, Bernard Zinman, David H Fitchett
Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA-REG OUTCOME. Diabetes, obesity & metabolism 22 (7) (2020)
Subodh Verma, Stephen C Bain, Tea Monk Fries, C David Mazer, Michael A Nauck, Richard E Pratley, Søren Rasmussen, Hans A Saevereid, Bernard Zinman, John B Buse
Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials. Diabetes, obesity & metabolism 21 (7) (2019)
A Sharma, J Butler, S Zieroth, N Giannetti, Subodh Verma
Treatment of heart failure with sodium glucose co-transporter-2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions. Diabetic medicine : a journal of the British Diabetic Association 36 (12) (2019)
Scott Cooper, Hwee Teoh, Marc Antoine Campeau, Subodh Verma, Richard L Leask
Empagliflozin restores the integrity of the endothelial glycocalyx in vitro. Molecular and cellular biochemistry 459 (1-2) (2019)
Subodh Verma, C David Mazer, Deepak L Bhatt, Satish R Raj, Andrew T Yan, Atul Verma, Eleuterio Ferrannini, Gudrun Simons, Jisoo Lee, Bernard Zinman, Jyothis T George, David Fitchett
Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial. Diabetes care 42 (3) (2019)